Lisa M. Meeks, PhD and Christopher Moreland, MD, MPH
Obstacles for applicants with disabilities illuminate admission practices that could help craft a clinical workforce that is appropriately diverse and prepared to give just, patient-centered care.
AMA J Ethics. 2021;23(12):E987-994. doi:
10.1001/amajethics.2021.987.
The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention.
AMA J Ethics. 2021;23(1):E49-54. doi:
10.1001/amajethics.2021.49.
Dr Lisa M. Meeks joins Ethics Talk to discuss her article, coauthored with Dr Christopher Moreland: “How Should We Build Disability-Inclusive Medical School Admissions?”
Dr Dorothy W. Tolchin joins Ethics Talk to discuss her article, coauthored with Nicole D. Agaronnik, Shahin A. Saberi, and Dr Michael Ashley Stein: “Why Disability Must Be Included in Medical School Diversification Efforts”
Deception’s justifiability might depend on clinicians’ commitment to solidarity and awareness of social determinants of patients’ vulnerability to HIV infection.
AMA J Ethics. 2021;23(5):E382-387. doi:
10.1001/amajethics.2021.382.
Rayner Kay Jin Tan, Jane Mingjie Lim, MSW, and Jeremiah Kah Wai Chan, MSc
Merits and drawbacks of U = U messaging are ethically and clinically complex, and drawbacks could harm patients in whom viral suppression is hard to achieve.
AMA J Ethics. 2021;23(5):E418-422. doi:
10.1001/amajethics.2021.418.